Role of precipitous virulence in invasiveness of community-acquired methicillin-r
急剧毒力在社区获得性甲氧西林-r侵袭性中的作用
基本信息
- 批准号:9194375
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbscessAcuteAffectAlienAnimal ModelAnti-Infective AgentsAttentionBacteriaBiological AssayCell DensityClinicalCommunitiesCutaneousDNA sequencingDataDefectDiseaseEventExhibitsFrequenciesFunctional disorderGene ExpressionGene Expression RegulationGene MutationGenesGeneticGenetic VariationGoalsHost DefenseHumanIn VitroIndividualInfectionInfectious Diseases ResearchInfectious Skin DiseasesIntegration Host FactorsInterventionKnowledgeLeadLifeLife StyleMapsMethicillinMicrobial BiofilmsMinorityModalityMutationOutcomePathogenesisPatientsPhenotypePlayPopulationProductionPropertyRecoveryRegulationRegulator GenesResearchRestRoleSerial PassageSigma FactorSiteStaphylococcus aureusSurveysSymbiosisTestingTherapeuticTherapeutic UsesTimeTissuesToxinVariantVirulenceVirulentWorkbacterial fitnessbasecomparativedesigndisease phenotypefield studyfitnessfitness testgenome sequencingimmune clearancein vivoindividual patientknockout genemembermethicillin resistant Staphylococcus aureusmutantpathogenpressurepreventprogramspublic health relevancequorum sensingscreeningwhole genome
项目摘要
DESCRIPTION (provided by applicant): Our long-term goal is a deeper understanding of how bacterial fitness and virulence intersect in pathogenesis. The present proposal focuses on the role of the Staphylococcal virulon in infections caused by community- acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA). While the outcome of a CA-MRSA encounter is usually asymptomatic colonization, the propensity of CA-MRSA strains to produce invasive infection defines a capacity to resist host innate immune clearance mechanisms. The CA-MRSA factors responsible for the diverse outcomes of this important host-pathogen interaction are unknown. The agr locus, a global regulator of virulence gene expression, has received much attention due to its critical role in invasiveness in animal models. Our preliminary data suggesting that invasion of CA-MRSA in humans is accompanied by enrichment for variants with enhanced agr activity supports this idea and indicates that the early stages of disease are accompanied by bacterial changes that give rise to an invasive-disease phenotype. DNA sequencing of such variants revealed that the agr locus was unaltered, indicating that "upstream" agr regulation contributes to the phenotype. Dysfunction of the alternative sigma factor sigB was identified as a frequent cause of the phenotype, but our preliminary survey of clinical isolates indicates the occurrence of alterations in other, unknown genes. Critically, variants had a fitness advantage in vitro, suggesting that selective pressures independent of host factors can account in part for their emergence. These considerations give rise to the following two-part hypothesis, upon which the present proposal is based: 1) through mutation of genes, S. aureus frequently generates within an infection a group of clones differing in their virulence, and 2) the shift of CA-MRSA strains from a commensal to an invasive-disease phenotype is associated with selection in vivo for mutations that enhance virulence. To test the hypothesis, we will 1) determine the frequency of within-host upshifts in agr function during clinical CA-MRSA skin infection and invasive disease, 2) characterize the genetic basis of these upshifts, and 3) evaluate the relative virulence and fitness of strains with upshifts both in vitro
and in vivo using serial passage and competition tests. Field studies will focus on community subjects, where the barrier to infection is higher than in hospitalized patients for whom disruption of barrier functions by disease and clinical intervention permit S. aureus strains that lack full virulence to cause infection. The proposed work will impact critical questions in infectious disease research, such as the best use of therapeutic modalities that are being developed to target agr and virulence, as well as more basic yet closely intertwined problems, such as the ways in which S. aureus transitions from an innocent member of our normal flora to an invasive, life-threatening pathogen. The work will have broad implications for forestalling such events.
描述(由申请人提供):我们的长期目标是更深入地了解细菌适应性和毒力如何在发病机制中交叉。目前的建议集中在葡萄球菌的作用,在社区获得性,耐甲氧西林金黄色葡萄球菌(CA-MRSA)引起的感染。虽然CA-MRSA遭遇的结果通常是无症状的定殖,但CA-MRSA菌株产生侵入性感染的倾向定义了抵抗宿主先天免疫清除机制的能力。CA-MRSA的因素负责这种重要的宿主-病原体相互作用的不同结果是未知的。agr基因座是一个全局性的毒力基因表达调控基因,由于其在动物模型中的侵袭性中的关键作用而受到广泛关注。我们的初步数据表明,CA-MRSA在人类中的入侵伴随着具有增强agr活性的变异体的富集,这支持了这一观点,并表明疾病的早期阶段伴随着细菌变化,这些细菌变化引起侵袭性疾病表型。这些变体的DNA测序显示,agr基因座是不变的,表明“上游”agr调节有助于表型。替代因子sigB的功能障碍被确定为表型的常见原因,但我们对临床分离株的初步调查表明其他未知基因发生了改变。重要的是,变异体在体外具有适应性优势,这表明独立于宿主因素的选择压力可以部分解释它们的出现。这些考虑引起了以下两部分假设,本建议是基于:1)通过基因突变,S。金黄色葡萄球菌在感染中经常产生一组毒力不同的克隆,2)CA-MRSA菌株从寄生性疾病表型到侵袭性疾病表型的转变与体内选择增强毒力的突变有关。为了验证这一假设,我们将1)确定临床CA-MRSA皮肤感染和侵袭性疾病期间宿主内agr功能上调的频率,2)表征这些上调的遗传基础,3)评估体外上调菌株的相对毒力和适应性。
并在体内使用连续传代和竞争试验。现场研究将集中在社区受试者,那里的感染屏障高于住院患者,对他们来说,疾病和临床干预允许屏障功能的破坏。缺乏引起感染的完全毒力的金黄色葡萄球菌菌株。拟议的工作将影响传染病研究中的关键问题,例如正在开发的针对agr和毒力的治疗方式的最佳使用,以及更基本但紧密交织的问题,例如S.金黄色葡萄球菌从我们正常植物群的无辜成员转变为侵入性的、威胁生命的病原体。这项工作将对预防此类事件产生广泛影响。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BO SHOPSIN其他文献
BO SHOPSIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BO SHOPSIN', 18)}}的其他基金
Host-pathogen interactions during hospital adaptation of MRSA
MRSA 医院适应期间宿主与病原体的相互作用
- 批准号:
10459365 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Host-pathogen interactions during hospital adaptation of MRSA
MRSA 医院适应期间宿主与病原体的相互作用
- 批准号:
10004561 - 财政年份:2019
- 资助金额:
$ 42.38万 - 项目类别:
Role of precipitous virulence in invasiveness of community-acquired methicillin-r
急剧毒力在社区获得性甲氧西林-r侵袭性中的作用
- 批准号:
8774580 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
Role of precipitous virulence in invasiveness of community-acquired methicillin-r
急剧毒力在社区获得性甲氧西林-r侵袭性中的作用
- 批准号:
8970671 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
Role of precipitous virulence in invasiveness of community-acquired methicillin-r
急剧毒力在社区获得性甲氧西林-r侵袭性中的作用
- 批准号:
8420767 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
Role of precipitous virulence in invasiveness of community-acquired methicillin-r
急剧毒力在社区获得性甲氧西林-r侵袭性中的作用
- 批准号:
8585817 - 财政年份:2012
- 资助金额:
$ 42.38万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 42.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Operating Grants














{{item.name}}会员




